Centessa Pharmaceuticals PLC ADR (CNTA) stock news · rev $15.0M
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
This CNTA news page leads with what Centessa Pharmaceuticals PLC ADR filed — not a scraped headline mill.
No cached 8-K sentence for CNTA yet. We will not pad this page with generic market recap.
Latest reported CNTA revenue for 2025-12-31 was $15.0M. Net income was -$197.5M. CNTA currently screens at market cap $6.15B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CNTA stock page; for the tape open the quote page.
CNTA stock news FAQ
What are CNTA's latest revenue and net income?
Latest cached Centessa Pharmaceuticals PLC ADR (CNTA) revenue for Dec 31, 2025 was $15.0M. Net income was -$197.5M. Statements: https://lician.com/financials/cnta
What is CNTA's market cap?
Centessa Pharmaceuticals PLC ADR (CNTA) market cap is $6.15B on the latest cached fundamentals snapshot.
What kind of company is CNTA?
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Where is CNTA stock news listed?
Cached stock news for Centessa Pharmaceuticals PLC ADR (CNTA) is listed at https://lician.com/news/cnta. Filings: https://lician.com/sec/cnta
Not investment advice.